232 related articles for article (PubMed ID: 16875033)
1. [The usefulness of routine laboratory tests in the evaluation of sudden threat of pregnant woman and fetus in pre-eclampsia].
Malarewicz A; Gruszka O; Szymkiewicz J; Rogala J
Ginekol Pol; 2006 Apr; 77(4):276-84. PubMed ID: 16875033
[TBL] [Abstract][Full Text] [Related]
2. [Delivery and perinatal aspects of pregnant women with pre-eclampsia-eclampsia].
Bozhinova S; Poroshanova V; Sampat D
Akush Ginekol (Sofiia); 2004; 43(7):3-9. PubMed ID: 15673046
[TBL] [Abstract][Full Text] [Related]
3. Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Feb; 47(2):194-202. PubMed ID: 26094952
[TBL] [Abstract][Full Text] [Related]
4. Biophysical and biochemical markers at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Feb; 47(2):203-9. PubMed ID: 26224608
[TBL] [Abstract][Full Text] [Related]
5. Serum uric acid levels as an index of fetal prognosis in pregnancies complicated by pre-existing hypertension and pre-eclampsia of pregnancy.
Varma TR
Int J Gynaecol Obstet; 1982 Oct; 20(5):401-8. PubMed ID: 6128272
[TBL] [Abstract][Full Text] [Related]
6. Induction or caesarean section for preterm pre-eclampsia?
Mashiloane CD; Moodley J
J Obstet Gynaecol; 2002 Jul; 22(4):353-6. PubMed ID: 12521452
[TBL] [Abstract][Full Text] [Related]
7. The psychological impact of providing women with risk information for pre-eclampsia: a qualitative study.
Harris JM; Franck L; Green B; Michie S
Midwifery; 2014 Dec; 30(12):1187-95. PubMed ID: 24917032
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal study of platelet size changes in gestation and predictive power of elevated MPV in development of pre-eclampsia.
Dundar O; Yoruk P; Tutuncu L; Erikci AA; Muhcu M; Ergur AR; Atay V; Mungen E
Prenat Diagn; 2008 Nov; 28(11):1052-6. PubMed ID: 18973157
[TBL] [Abstract][Full Text] [Related]
9. [Predictive value of placenta-derived RASSF1A sequence expression in maternal plasma for pre-eclampsia].
Wang J; Yang J; Wu X; Mu Y; Li S; Cui K; Wang X; Zhao F
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Feb; 31(1):25-8. PubMed ID: 24510557
[TBL] [Abstract][Full Text] [Related]
10. Can serum HCG values be used in the differential diagnosis of pregnancy complicated by hypertension?
Gurbuz A; Karateke A; Mengulluoglu M; Gedikbasi A; Ozturkmen M; Kabaca C; Sahinoglu Z
Hypertens Pregnancy; 2004; 23(1):1-12. PubMed ID: 15117595
[TBL] [Abstract][Full Text] [Related]
11. Takotsubo syndrome occurring concomitantly with pre-eclampsia: A case report.
Horie K; Takahashi H; Fujimoto Y; Kaneko D; Yada Y; Matsubara S
J Obstet Gynaecol Res; 2019 May; 45(5):1071-1075. PubMed ID: 30689260
[TBL] [Abstract][Full Text] [Related]
12. First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia.
Wortelboer EJ; Koster MP; Cuckle HS; Stoutenbeek PH; Schielen PC; Visser GH
BJOG; 2010 Oct; 117(11):1384-9. PubMed ID: 20840693
[TBL] [Abstract][Full Text] [Related]
13. Plasma noradrenaline and adrenaline in pre-eclampsia, essential hypertension in pregnancy and normotensive pregnant control subjects.
Pedersen EB; Rasmussen AB; Christensen NJ; Johannesen P; Lauritsen JG; Kristensen S; Wohlert M
Acta Endocrinol (Copenh); 1982 Apr; 99(4):594-600. PubMed ID: 7072455
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of fetal hypermethylated RASSF1A in pre-eclampsia and its relationship with placental protein-13, pregnancy associated plasma protein-A and urine protein.
Saraswathy S; Sahai K; Yadav TP; Arora D; Mendiratta SL; Naqvi SH; Biswas S; Krishnan M; Abraham KM
Pregnancy Hypertens; 2016 Oct; 6(4):306-312. PubMed ID: 27939474
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the female fetal DNA concentration in the plasma of the pregnant women as preeclampsia indicator--preliminary report.
Karina E; Tomasz P; Bilar M; Agnieszka O; Ewa B; Elzbieta RW
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):165-8. PubMed ID: 19632756
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of serum uric acid as a predictive test for maternal complications in pre-eclampsia: bivariate meta-analysis and decision analysis.
Koopmans CM; van Pampus MG; Groen H; Aarnoudse JG; van den Berg PP; Mol BW
Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):8-14. PubMed ID: 19540647
[TBL] [Abstract][Full Text] [Related]
17. Maternal and umbilical venous levels of endothelin in women with pre-eclampsia.
Tsunoda K; Abe K; Yoshinaga K; Furuhashi N; Kimura H; Tsujiei M; Yajima A
J Hum Hypertens; 1992 Feb; 6(1):61-4. PubMed ID: 1583632
[TBL] [Abstract][Full Text] [Related]
18. Routine investigations might be useful in pre-eclampsia, but not in gestational hypertension.
Bailey DJ; Walton SM
Aust N Z J Obstet Gynaecol; 2005 Apr; 45(2):144-7. PubMed ID: 15760317
[TBL] [Abstract][Full Text] [Related]
19. Cell-Free Fetal DNA: A Novel Biomarker for Early Prediction of Pre-eclampsia and Other Obstetric Complications.
Kumar N; Singh AK
Curr Hypertens Rev; 2019; 15(1):57-63. PubMed ID: 29766818
[TBL] [Abstract][Full Text] [Related]
20. Serum visfatin levels in late pregnancy and pre-eclampsia.
Hu W; Wang Z; Wang H; Huang H; Dong M
Acta Obstet Gynecol Scand; 2008; 87(4):413-8. PubMed ID: 18382866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
